CSL: Driving innovation through strategic collaborations
Networking Event with CSL
We are already fully booked. Please contact us if you wish to be included on the waiting list. We will send you a confirmation if a seat becomes available.
Join this biotech networking event series, powered by Innosuisse and gain deep insights into translating groundbreaking science into successful biotech companies to meet patient needs.
CSL is a global biotechnology leader with a dynamic portfolio of lifesaving medicines, including treatments for hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Founded in 1916, CSL has been driven by the promise to save lives using the latest technologies. Today, CSL, including its three businesses—CSL Behring, CSL Seqirus, and CSL Vifor—provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
The discussion will feature CSL leadership spanning the drug discovery value chain, exploring topics from pioneering translational biology to innovative biopharmaceutical development strategies.
Program
17:00
Door opening
17:30
Welcome by BaseLaunch
17:35
Welcome address & keynote speech
- Michael Larbig, Moderator and Executive Director, Global Clinical Program Leader, Respiratory, CSL Behring AG
17:50
Panel discussion: "Pioneering patient solutions in biotech and healthcare"
- Michael Larbig, Moderator and Executive Director, Global Clinical Program Leader, Respiratory, CSL Behring AG
- Vicky Pirzas, SVP, Biopharmaceutical Development, Global R&D, CSL Behring AG
- Leslie Bannon, Enterprise Head of Alliances Strategy & Business Development, CSL Behring AG
- Christoph Rösli, Director, Research Bern Platforms,
- Lars Groenke, Managing Director & Vice President Global R&D, CSL Behring AG
18:40
Q&A session
19:10
Networking apéro
Partners
